Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
22.37
-0.42 (-1.82%)
Nov 5, 2024, 11:14 AM EST - Market open
Genmab Market Cap
Genmab has a market cap or net worth of $14.40 billion as of November 5, 2024. Its market cap has decreased by -23.91% in one year.
Market Cap
14.40B
Enterprise Value
12.25B
1-Year Change
-23.91%
Ranking
Category
Stock Price
$22.22
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $14.40B, an increase of 3,323.44%. That is a compound annual growth rate of 32.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 14.92B | -29.07% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Natera | 15.36B |
| Avantor | 15.18B |
| Revvity | 14.93B |
| Tenet Healthcare | 14.85B |
| Incyte | 14.67B |
| Summit Therapeutics | 14.00B |
| Viatris | 13.87B |
| Universal Health Services | 13.69B |